专场1：乳腺癌基础科学
Track 1：Basic Sciences
分会报告1-1：乳腺癌分子肿瘤学
Track 1-1: Molecular Oncology on Breast Cancer
分会报告1-2：乳腺癌病理学与毒理学
Track 1-2: Pathology and Toxicology of Breast Cancer
分会报告1-3：乳腺癌基因组学、表观遗传学、蛋白质组学
Track 1-3: The Cancer Genomics, Epigenics and Proteomics
分会报告1-4：乳腺癌流行病学、遗传学与预防
Track 1-4: Epidemiology, Genetics and Prevention
分会报告1-5：乳腺癌免疫学与免疫治疗
Track 1-5: Immunology and Immunotherapy of Breast Cancer
分会报告1-6：炎性乳腺癌
Track 1-6: Inflammatory Breast Cancer
分会报告1-7：乳腺癌干细胞/ 祖细胞
Track 1-7: Stem/Progenitor Cells
分会报告1-8：肿瘤的发展、侵袭和转移
Track 1-8: Tumor Progression, Invasion and Metastasis
分会报告1-9：肿瘤微环境与乳腺癌
Track 1-9: Tumor Microenvironment and Breast Cancer
分会报告1-10:内分泌与乳腺癌
Track 1-10: Endocrinology and Breast Cancer
分会报告1-11: 乳腺癌的转化研究
Track 1-11: Translational Research in Breast Cancer
分会报告1-12: 生长因子，激素因子和受体
Track 1-12: Growth Factors, hormonal Factors and Receptors
分会报告1-13: 动物模型和新模型
Track 1-13: Animal Models and Novel Models
分会报告1-14: 乳腺癌滤过性微生物学
Track 1-14: Virology of Breast Cancer
分会报告1-15: 致癌基因与抑癌基因
Track 1-15: Oncogenes/Tumor Suppressor Genes
专场2 ：乳腺癌生物标记
Track 2: Breast Cancer Biomarkers
分会报告2-1：基因表达微阵列和复发预测
Track 2-1: Gene Expression Microarrays and Recurrence Prediction
分会报告2-2：通路分析中的生物标志物
Track 2-2: Biomarkers in Pathway Analysis
分会报告2-3: 用于分子诊断的生物标志物
Track 2-3: Molecular Diagnostics with Biomarkers
专场3 ：乳腺癌新药发现与开发
Track 3: Breast Cancer Drug Discovery and Development
分会报告 3-1: 分子靶标有效性确认，新药设计及发现化学
Track 3-1: Molecular Target Validations, Drug Designs and Discovery Chemistry
分会报告 3-2: 基因克隆和基因表达谱
Track 3-2: Gene Cloning and Gene Expression Profiling
分会报告 3-3: RNA干扰, 微小RNA, 非编码RNA和小干扰RNA
Track 3-3: RNAi, microRNA, ncRNA and siRNA
分会报告 3-4: 生物信息学和计算机辅助药物设计
Track 3-4: Bioinformatics and Computer Aided Drug Design
分会报告 3-5: 生物标志物在乳腺癌新药发现中的应用
Track 3-5: Biomarkers in Breast Cancer Drug Discovery
分会报告 3-6: 靶向生长因子
Track 3-6: Targeting Growth Factors
分会报告 3-7: 靶向核受体和激素受体以及内分泌治疗
Track 3-7: Targeting Nuclear and Hormone Receptor and Endocrine Therapy
分会报告 3-8: 靶向HER2/neu二聚体
Track 3-8: Targeting HER2/neu Dimerisation
分会报告 3-9: 靶向血管生成
Track 3-9: Targeting Angiogenesis
分会报告 3-10: 靶向法尼基化
Track 3-10: Targeting Farnesylation
分会报告3-11：靶向MEK和mTOR通路以及其它新兴信号通路
Track 3-11: Targeting the MEK and the mTOR Pathway and other Novel Signaling Pathways
分会报告3-12：靶向细胞周期和凋亡
Track 3-12: Targeting Cell Cycle & Apoptosis
分会报告3-13：靶向DNA合成和修复
Track 3-13: Targeting DNA Synthesis and Repair
分会报告3-14：靶向蛋白酶体
Track 3-14: Targeting the Proteasome
分会报告3-15：抑制细胞生长
Track 3-15: Inhibiting Cell Growth
分会报告3-16：抗磷脂疗法
Track 3-16: Anti-phospholipid Therapy
分会报告3-17：辅助、新辅助和转移激素疗法
Track 3-17: Adjuvant, Neoadjuvant and Metastatic Hormonal Therapy
分会报告3-18：SERMs, 芳香酶抑制剂, and SERDs
Track 3-18: SERMs, Aromatase Inhibitors, and SERDs
专场4：乳腺癌临场远景，诊断和病人管理
Track 4: Clinical Perspective, Diagnostics and Patient Management
分会报告4-1: 乳腺癌中的分子诊断
Track 4-1: Molecular Diagnostics in Breast Cancer
分会报告 4-2: 乳腺癌中诊断病理学及预后预测
Track 4-2: Diagnostic Pathology, and Prognostics in Breast Cancer
分会报告4-3: 解剖学上的乳腺影像：乳房造影法，断层X(射)线照相组合，超声及磁共振成像
Track 4-3: Anatomic Breast Imaging: Mammography, Tomosynthesis, Ultrasound, MRI
分会报告 4-4: 功能性/分子乳腺成像术：正电子发射乳房造影术，γ射线乳房造影术， 光学乳腺癌成像技术
Track 4-4: Functional/Molecular Breast Imaging: PEM, GSBI, Optical Breast Imaging
分会报告4-5: 腋窝分期与前哨淋巴结
Track 4-5: Axillary Staging and Sentinel Nodes
分会报告4-6：活体检验技术
Track 4-6: Biopsy Techniques
分会场4-7: 血液循环中的肿瘤标志物
Track 4-7: Circulating Markers
分会场 4-8: 髓和血液的微转移
Track 4-8: Marrow and Blood Micrometastases
分会报告4-9: 成像引导的乳腺癌分期/再分期：正电子发射断层摄影(术), 磁共振
Track 4-9: Imaging-Guided Staging/Re-staging of Breast Cancer: PET, MRI
分会报告4-10: 筛选与检测
Track 4-10: Screening and Detection
专场5 ：乳腺癌治疗，临床远景和管理
Track 5: Breast Cancer Therapy, Clinical Perspective and Management
分会报告5-1：辅助化疗和辅助靶向疗法
Track 5-1: Adjuvant Chemotherapy and Adjuvant Targeted Therapy
分会报告5-2：针对不同时期乳腺癌的放射治疗
Track 5-2: Tailored Radiation Therapy for Breast Cancer Stages
分会报告5-3：先进的化学疗法
Track 5-3: Advanced Chemotherapy
分会报告5-4：先进的内分泌疗法
Track 5-4: Advanced Endocrine Therapy
分会报告5-5：先进的乳腺癌靶向疗法
Track 5-5: Advanced Targeted Breast Cancer Therapy
分会报告5-6：生物疗法
Track 5-6: Biological Therapy
分会报告5-7：耐药性治疗
Track 5-7: Drug Resistance Management
分会报告5-8：基于抗体的治疗方案
Track 5-8: Antibody-Based Regimens
分会报告5-9：个体化的早期乳腺癌手术和乳腺癌肝脏转移的外科治疗
Track 5-9: Tailored Surgery for Early Breast Cancer and Surgical Management of Breast Cancer Liver Metastases
分会报告5-10：器官特异性的方法：疼痛处理
Track 5-10: Organ-Specific Approaches: Pain Management
分会报告5-11：乳腺癌和其他恶性肿瘤的最新理论推导的，以靶向为基础的和细胞毒性疗法
Track 5-11: Innovative Rational-Derived, Target-Based and Cytotoxic Therapies for Breast Cancer and Other Malignancies
分会报告5-12：乳腺原位癌：病人管理和综合治疗
Track 5-12: Ductal Carcinoma In Situ: Patient Management and Systemic Treatment |
